{'fraction_non_alphanumeric': 0.01949317738791423, 'fraction_numerical': 0.012670565302144249, 'mean_word_length': 5.583333333333333, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Intracranial hemorrhage with COVID 19 patient; case report

Coronavirus disease is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). Although the majority of patients with COVID19 typically have characteristic respiratory presentations, a large number of patients were presented with multi-system affection included central nervous system. The neurotropic features of SARS-CoV2 account for the damaging effects of this virus on the central nervous system. This was initially evidenced by reports from Beijing Ditan Hospital of the first case of viral encephalitis due to COVID 19. A growing number of case reports and series have been published describing the clinical characteristics of patients with ischemic strokes and COVID-19. These emerging reports, including large vessel occlusion, brain infarcts, venous thromboembolism and raised inflammatory markers. We reported a case of an intracranial hemorrhage (ICH) in our hospital in diabetic hypertensive patients infected with confirmed COVID 19.